BioInvent International AB (publ)

OM:BINV Stock Report

Market Cap: SEK 2.5b

BioInvent International Future Growth

Future criteria checks 5/6

BioInvent International is forecast to grow earnings and revenue by 108.6% and 90.4% per annum respectively while EPS is expected to grow by 196.4% per annum.

Key information

108.6%

Earnings growth rate

196.4%

EPS growth rate

Biotechs earnings growth42.4%
Revenue growth rate90.4%
Future return on equityn/a
Analyst coverage

Low

Last updated02 Nov 2024

Recent future growth updates

Recent updates

Is BioInvent International (STO:BINV) In A Good Position To Invest In Growth?

Aug 16
Is BioInvent International (STO:BINV) In A Good Position To Invest In Growth?

We Think BioInvent International (STO:BINV) Needs To Drive Business Growth Carefully

Apr 09
We Think BioInvent International (STO:BINV) Needs To Drive Business Growth Carefully

Companies Like BioInvent International (STO:BINV) Are In A Position To Invest In Growth

Sep 01
Companies Like BioInvent International (STO:BINV) Are In A Position To Invest In Growth

Earnings Working Against BioInvent International AB (publ)'s (STO:BINV) Share Price Following 29% Dive

Jun 02
Earnings Working Against BioInvent International AB (publ)'s (STO:BINV) Share Price Following 29% Dive

Analysts Are Betting On BioInvent International AB (publ) (STO:BINV) With A Big Upgrade This Week

Feb 25
Analysts Are Betting On BioInvent International AB (publ) (STO:BINV) With A Big Upgrade This Week

We're Hopeful That BioInvent International (STO:BINV) Will Use Its Cash Wisely

Sep 28
We're Hopeful That BioInvent International (STO:BINV) Will Use Its Cash Wisely

Time To Worry? Analysts Just Downgraded Their BioInvent International AB (publ) (STO:BINV) Outlook

Aug 31
Time To Worry? Analysts Just Downgraded Their BioInvent International AB (publ) (STO:BINV) Outlook

Earnings and Revenue Growth Forecasts

OM:BINV - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202657822N/A221
12/31/2025589356N/A-231
12/31/202430-360N/A-4301
9/30/202439-410-366-355N/A
6/30/202453-383-376-364N/A
3/31/202461-335-341-329N/A
12/31/202371-330-355-342N/A
9/30/202377-311-358-341N/A
6/30/202368-304-77-62N/A
3/31/2023326-48-53-40N/A
12/31/2022326-43-54-41N/A
9/30/2022310-43-54-45N/A
6/30/2022295-42-289-276N/A
3/31/202230-266-290-276N/A
12/31/202119-278-259-246N/A
9/30/2021113-171-153-141N/A
6/30/2021126-141-123-115N/A
3/31/2021137-123-85-78N/A
12/31/2020147-76-69-63N/A
9/30/202074-146-125-119N/A
6/30/202076-150-117-112N/A
3/31/202093-144-124-120N/A
12/31/201994-139-129-125N/A
9/30/201979-130-139-136N/A
6/30/201968-116-152-148N/A
3/31/201945-126-156-152N/A
12/31/201839-123-145-141N/A
9/30/201842-124-136-126N/A
6/30/201842-123N/A-116N/A
3/31/201843-103N/A-99N/A
12/31/201745-101N/A-76N/A
9/30/201762-75N/A-76N/A
6/30/201756-82N/A-75N/A
3/31/201755-85N/A-81N/A
12/31/201671-63N/A-72N/A
9/30/201650-76N/A-59N/A
6/30/201651-70N/A-46N/A
3/31/201645-69N/A-50N/A
12/31/201516-91N/A-73N/A
9/30/20158-98N/A-87N/A
6/30/201517-86N/A-79N/A
3/31/201546-57N/A-73N/A
12/31/201447-54N/A-76N/A
9/30/201495-5N/A-27N/A
6/30/201492-10N/A-42N/A
3/31/201472-23N/A-55N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BINV is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.2%).

Earnings vs Market: BINV is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: BINV is expected to become profitable in the next 3 years.

Revenue vs Market: BINV's revenue (90.4% per year) is forecast to grow faster than the Swedish market (1.2% per year).

High Growth Revenue: BINV's revenue (90.4% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if BINV's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/01 16:07
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioInvent International AB (publ) is covered by 9 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Morten LarsenABG Sundal Collier
Camilla OxhamreCarnegie Investment Bank AB
Mattias HäggblomDanske Bank